Full history for every metric is available with a Kvantra account
Bioter S.A. (BIOT.AT)
Key financial summary
Financials in EUR| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Operating profit | €m | -12 | -19 | |||||
| Net profit | €m | -9 | 6 | -9 | -10 | -12 | -21 | 38 |
| EPS reported | € | -1.27 | 2.30 | |||||
| Operating cashflow per share | € | -0.71 | -0.71 | |||||
| Capex per share | € | 0.01 | 0.01 | |||||
| FCF per share | € | -0.72 | -0.72 | |||||
| Free cash flow | €m | -12 | 49 | |||||
| Net debt | €m | 190 | 133 | |||||
| Book value equity | €m | -139 | -85 | |||||
| Book value per share | € | -8.31 | -5.08 | |||||
| Number of shares | m | 16.73 | 16.73 | |||||
| DPS (TTM paid) | € | 0.00 | 0.00 |
Financial summary
Financials in EUR| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.03 | -0.04 | |||||
| P/S LTM | x | 3.33 | 2.73 | |||||
| P/FCF LTM | x | -0.35 | 0.07 | |||||
| EV/EBITDA LTM | x | -16.29 | 3.21 | |||||
| EV/Sales LTM | x | 154.43 | 108.33 | |||||
| Earnings Yield LTM | % | -508.12% | -616.65% | |||||
| FCF Yield | % | -288.07% | 1415.1% | |||||
| Quality | ||||||||
| ROE | % | 15.28% | 16.55% | |||||
| ROIC | % | -21.36% | -21.36% | |||||
| Operating margin | % | -955.70% | -955.70% | |||||
| Gross margin | % | 76.33% | 76.33% | |||||
| FCF/Sales | % | -960.32% | -960.32% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +151.50% | +350.71% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.06 | 0.36 | |||||
| Net Debt/EBITDA | x | -15.94 | -15.94 | |||||
| EBIT/Net interest | x | -1.09 | -1.09 | |||||
| Net debt/market cap | % | 4532.3% | 3865.8% | |||||
| Net debt/Equity | x | -1.36 | -1.57 | |||||
| Gross debt/equity | x | -1.37 | -1.57 | |||||
Company overview
Bioter S.A. functions as an engineering and construction company, with operations extending throughout Greece and globally. Its diverse project portfolio includes the development of critical infrastructure such as roads, ports, airports, and specialized facilities for industrial, energy, and defense sectors, alongside complex electromechanical and communication systems. The firm also engages in private construction, delivering commercial properties like office complexes, banking premises, and automotive service centers. Founded in 1961, Bioter S.A. has its headquarters in Athens, Greece.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Bioter S.A. (BIOT.AT)
Bioter S.A. functions as an engineering and construction company, with operations extending throughout Greece and globally. Its diverse project portfolio includes the development of critical infrastructure such as roads, ports, airports, and specialized facilities for industrial, energy, and defense sectors, alongside complex electromechanical and communication systems. The firm also engages in private construction, delivering commercial properties like office complexes, banking premises, and automotive service centers. Founded in 1961, Bioter S.A. has its headquarters in Athens, Greece.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free